Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Exanthema × benralizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hematologic Neoplasms 1 Exanthema 1 Breast Neoplasms 1

Interventions

Fulvestrant 2 ruxolitinib 1 ceterizine hydrochloride 1 capivasertib 1 benralizumab 1 Sirolimus 1 Prednisone 1 Panitumumab 1 Loperamide 1 Irinotecan 1 IFL protocol 1 Gels 1 Doxycycline 1 Dapsone 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05966584 2024-08-29

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated

1 enrolled 5 charts

Breast Neoplasms, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡